Primary contact

SolveBio has developed an advanced precision medicine technology platform — called Genomic Intelligence Platform — that enables biopharma customers to lower trial risk, create more effective therapeutics, and compress the time scale of clinical development. The company's technology can connect genomic data to outcomes from a rapidly compounding complex landscape of vendors, studies, and patients.
Primary contact

Funding 💰

Total $3.5M
Select investors Andreessen Horowitz, SV Angel, Red Swan Ventures, Great Oaks Venture Capital, Faridan, Max Levchin
Last update: June 10, 2018